Progress of CD8+CD25+regulatory T cells in diseases

doi:10.16352/j.issn.1001-6325.2022.12.1939

Abstract

Abstract: CD8⁺CD25⁺Treg can inhibit immune response and induce immune tolerance. This article reviews the changes and underlying mechanisms of CD8⁺CD25⁺Treg in pathogenesis of malignant tumors, autoimmune diseases and other common diseases such as asthma, allergic diseases, type 2 diabetes, and pre-eclampsia. The changes of CD8⁺CD25⁺Treg in different diseases are inconsistent, cell counting increased in malignant diseases but decreased in autoimmune diseases. Further understanding of CD8⁺CD25⁺Treg would supporte a basis for the prevention, treatment and improving prognosis of these diseases.

Key words: CD8⁺CD25⁺Treg, CD8⁺ Treg, regulatory T cells, autoimmune diseases, tumors

CLC Number:

WEN Li-na, CHEN Li, DUAN Rui, LI Fang. Progress of CD8⁺CD25⁺regulatory T cells in diseases[J]. Basic & Clinical Medicine, 2022, 42(12): 1939-1944.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.12.1939

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I12/1939

References

[1]Li A, Herbst RH, Canner D, et al. IL-33 Signaling alters regulatory T Cell diversity in support of tumor development[J]. Cell Rep, 2019, 29: 2998-3008.
[2]Cosmi L, Liotta F, Lazzeri E, et al. Human CD8⁺CD25⁺ thymocytes share phenotypic and functional features with CD4⁺CD25⁺ regulatory thymocytes[J]. Blood, 2003, 102: 4107-4114.
[3]周文超, 蔡祥胜, 熊小敏, 等. CD4~+CD25~+CD127~(Low)调节性T细胞在原发性肝癌患者外周血的表达及临床意义[J]. 国际检验医学杂志, 2020, 41: 403-405+409.
[4]Troncone E, Monteleone G. Smad7 and colorectal carcinogenesis: a double-edged sword[J]. Cancers (Basel), 2019,11:612. doi: 10.3390/cancers11050612.
[5]Olguín JE, Medina-Andrade I, Molina E, et al. Early and partial reduction in CD4(+)Foxp3(+) Regulatory T Cells during colitis-associated colon cancer induces CD4(+) and CD8(+) T Cell activation inhibiting tumorigenesis[J]. J Cancer, 2018, 9: 239-249.
[6]陈书平, 巫艳彬, 吴聪. CD8~+CD25~+FOXP3~+调节性T淋巴细胞在恶性胸腔积液中的表达及其临床意义[J]. 中国癌症防治杂志, 2010, 2: 296-300.
[7]Zahran AM, Nafady-Hego H, Mansor SG, et al. Increa-sed frequency and FOXP3 expression of human CD8(+)CD25(High+) T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma[J]. Hum Immunol, 2019, 80: 510-516.
[8]Zhang S, Wu M, Wang F. Immune regulation by CD8⁺ Treg cells: novel possibilities for anticancer immuno-therapy[J]. Cell Mol Immunol, 2018 Sep;15:805-807.
[9]卢永红.卵巢癌患者组织及外周血CD8~+T细胞中调节性T细胞相关分子标志物的表达及意义[J].实用癌症杂志,2019,34:1271-1274.
[10]Notley CA, Mccann FE, Inglis JJ, et al. ANTI-CD3 therapy expands the numbers of CD4⁺ and CD8⁺ Treg cells and induces sustained amelioration of collagen-induced arthritis[J]. Arthritis Rheum, 2010, 62: 171-178.
[11]Fischer R, Proske M, Duffey M, et al. Selective activa-tion of tumor necrosis factor receptor Ⅱ induces antiinflammatory responses and alleviates experimental arth-ritis[J]. Arthritis Rheumatol, 2018, 70: 722-735.
[12]Tsai YG, Lee CY, Lin TY, et al. CD8⁺ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria[J]. PLoS One, 2014,9:e81344. doi: 10.1371/journal.pone.0081344.
[13]Mishra S, Liao W, Liu Y, et al. TGF-β and Eomes control the homeostasis of CD8⁺ regulatory T cells[J]. J Exp Med, 2021,218:e20200030. doi: 10.1084/jem.20200030.
[14]买文丽, 韩清娟, 曹文轩, 等. 人源化NOD小鼠中CD8~+CD25~+Tregs的频率和功能研究[J]. 免疫学杂志, 2016, 32: 7-12.
[15]Zhang M, Wang S, Guo B, et al. An altered CD8(+) T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice[J]. Cell Mol Immunol, 2019, 16: 590-601.
[16]Correale J, Villa A. Role of CD8⁺ CD25⁺ FoxP3⁺ regulatory T cells in multiple sclerosis[J]. Ann Neurol, 2010, 67: 625-638.
[17]Eusebio M, Kraszula L, Kupczyk M, et al. Interleukin-2-mediated stat-5 expression levels in CD8⁺CD25⁺ regulatory T cells: the relevance for asthma[J]. J Biol Regul Homeost Agents, 2019,33:1747-1754.
[18]Tsai YG, Yang KD, Wen YS, et al. Allergen-specific immunotherapy enhances CD8⁺CD25⁺CD137+ regulatory T cells and decreases nasal nitric oxide[J]. Pediatr Allergy Immunol,2019,30:531-539.
[19]Lin L, Dai F, Wei J, et al. Influences of CD8⁺ Tregs on peripheral blood mononuclear cells from allergic rhinitis patients[J]. Laryngoscope, 2021,131:E316-E323.
[20]毛亚静, 陆勤, 奚杰, 等. 内皮细胞微粒与CD8~+ CD25~+ FoxP3~+调节T细胞对子痫前期发生发展的作用探究[J]. 中国计划生育和妇产科, 2019, 11: 57-60.
[21]朱静和,蒋凤,刘青员,等.CD8~+CD25~+FoxP3~+调节T细胞在新诊断2型糖尿病患者外周血中的变化及其临床意义[J].中国糖尿病杂志,2020,28:202-206.
[22]Gupta S, Su H, Agrawal S. CD8 Treg cells inhibit B-cell proliferation and immunoglobulin production[J]. Int Arch Allergy Immunol, 2020,181:947-955.
[23]Churlaud G, Pitoiset F, Jebbawi F, et al. Human and mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at steady state and during Interleukin-2 Therapy[J]. Front Immunol, 2015,6:171. doi:10.3389/fimmu.2015.00171.
[24]Van ZL, Arroyo HR, Côrte-Real BF, et al. Fast and efficient genome editing of human FoxP3⁺ Regulatory T Cells[J]. Front Immunol,2021,12:655122.doi: 10.3389/fimmu.2021.655122.

Progress of CD8⁺CD25⁺regulatory T cells in diseases

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

Comments

[1]	QIN Zhi-hui, TAN De-min, WANG Wang-zhen, ZHANG Yao. LRCH1 maintains the function of regulatory T cells in mouse models of lupus nephritis [J]. Basic & Clinical Medicine, 2022, 42(3): 441-447.
[2]	LIU Lang, WANG Hai-cun, GAO Xin, LIU Guang-lin, ZHAO Yu-qiao, JIANG Xing-ming. Research progress of circular RNA zinc finger RNA binding protein in malignant tumors [J]. Basic & Clinical Medicine, 2022, 42(10): 1585-1590.
[3]	ZHAO Yu-qiao, SU Zhi-lei, CUI Yun-fu, GUAN Cang-hai, JIANG Xing-ming. Regulatory effects and mechanisms of HOTAIRM1 in malignant tumors [J]. Basic & Clinical Medicine, 2021, 41(2): 262-266.
[4]	ZHANG Yue-yi, LI Mei-zi, YANG Ying-yun, YANG Ai-ming. Advances in the role of interferon-induced proteins with tetratricopeptide repeats(TPR) in digestive system tumors [J]. Basic & Clinical Medicine, 2021, 41(11): 1662-1665.
[5]	. Research progress of long non-coding RNA in autoimmune diseases [J]. Basic & Clinical Medicine, 2019, 39(4): 573-576.
[6]	WANG Zhan. Advances of proline-rich protein tyrosine kinase 2 in tumors [J]. Basic & Clinical Medicine, 2019, 39(4): 585-588.
[7]	. Research progress on the fuction of lncRNAs in autoimmune diseases [J]. Basic & Clinical Medicine, 2018, 38(11): 1606-1610.
[8]	. Research progress of cellular autophagy induced by sonodynamic therapy in tumors and atherosclerosis [J]. Basic & Clinical Medicine, 2018, 38(11): 1620-1624.
[9]	. The effect of wet hyperthermia combined with microwave ablation on the proportion and function of CD4+CD25+ regulatory T cell in animal model of mouse mammary carcinoma [J]. Basic & Clinical Medicine, 2015, 35(9): 1188-1193.
[10]	. Immune-modulation of cord blood-derived multipotent stem cells on lymphocytes of patients with Alzheimer’s disease [J]. Basic & Clinical Medicine, 2015, 35(5): 654-660.
[11]	. The quantity and phenotype change of regulatory T cell in the model of mice liver transplantation [J]. Basic & Clinical Medicine, 2015, 35(3): 360-365.
[12]	. Progress on OLFM4 in common digestive system tumors [J]. Basic & Clinical Medicine, 2014, 34(1): 134-137.
[13]	Jun-ying ZHOU; Feng WEI; Jun-qing LI. Programmed death receptor 1 and viral hepatitis C [J]. Basic & Clinical Medicine, 2010, 30(11): 1218-1221.